Spexis announces closing of sale of preclinical antibiotics program to Basilea - adhoc - Börsennachrichten
Spexis AG Key word Miscellaneous Spexis announces closing of sale of preclinical antibiotics program to Basilea 08Feb2024 0715 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issu